IP Library Granted Patent US 8,680,053
Granted Patent B2
US 8,680,053 · App. 12/169,869 · Granted Mar 25, 2014

Improving renal function with quercetin-containing compositions

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,680,053
App. No.
12/169,869
Granted
Mar 25, 2014
Kind
B2
Abstract

This invention relates to a method of improving renal function by administering to a subject in need thereof an effective amount of a composition containing quercetin, vitamin C, vitamin B3, and folic acid.

Claims (13)

1. A method for increasing glomerular filtration rate, the method comprising identifying a subject in need of increased glomerular filtration rate and administering to the subject in need thereof an effective amount of a composition containing quercetin, vitamin C, vitamin B3, and folic acid.

2. The method of claim 1 , wherein the composition has a weight ratio of 1:0.2-2.5:0.02-1:0.2-2 (mg/mg/mg/mcg) between quercetin, vitamin C, vitamin B3, and folic acid.

3. The method of claim 2 , wherein the weight ratio is 1:0.5-1:0.02-0.2:0.5-1 (mg/mg/mg/mcg) between quercetin, vitamin C, vitamin B3, and folic acid.

4. The method of claim 3 , wherein the weight ratio is 1:1:0.04:0.8 (mg/mg/mg/mcg).

5. The method of claim 1 , wherein the effective amount of the composition is an amount that provides 500-2000 mg quercetin, 500-2000 mg vitamin C, 20-60 mg vitamin B3, and 400-800 mcg folic acid per day.

6. The method of claim 5 , wherein the effective amount of the composition is an amount that provides 500 mg quercetin, 500 mg vitamin C, 20 mg vitamin B3, and 400 mcg folic acid per day.

7. The method of claim 5 , wherein the effective amount of the composition is an amount that provides 1000 mg quercetin, 1000 mg vitamin C, 40 mg vitamin B3, and 800 mcg folic acid.

8. The method of claim 1 , wherein the composition is in dry form.

9. The method of claim 1 , wherein the composition is in liquid form.

10. The method of claim 1 , wherein the composition is a food product.

11. The method of claim 10 , wherein the food product is tea, juice, milk, coffee, a soft drink, jelly, ice cream, yogurt, cereal, chocolate, a cookie, or a snack bar.

12. The method of claim 1 , wherein the composition is a dietary supplement or a pharmaceutical formulation.

13. The method of claim 12 , wherein the composition is in the form of a tablet, a capsule, a soft chew, or a gel.

Assignments (5)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 18, 2020
From: QUERCEGEN PHARMA A.G.
To: LINES, THOMAS CHRISTIAN
Reel/Frame 052151/0234 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 18, 2020
From: LINES, THOMAS CHRISTIAN
To: QUERCIS PHARMA A.G.
Reel/Frame 052153/0756 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 13, 2020
From: LINES, THOMAS; QUERCEGEN PHARMA LLC; QUERCEGEN PHARMA LLP; QUERCEGEN TECHNOLOGIES; QUERCEGEN PHARMACEUTICALS, LLC; QUERCEGEN HOLDINGS, LLC; NEW SUN NUTRITION, LLC; THE FRS COMPANY
To: QUERCEGEN PHARMA, AG.
Reel/Frame 052110/0530 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 20, 2010
From: QUERCEGEN PHARMA LLC
To: QUERCEGEN PHARMACEUTICALS LLC
Reel/Frame 025527/0246 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 19, 2009
From: LINES, THOMAS CHRISTIAN
To: QUERCEGEN PHARMA LLC
Reel/Frame 022700/0837 →